Churg-Strauss Syndrome Life Expectancy

Last reviewed

With treatment, most people with Churg-Strauss syndrome live for many years. Without treatment it can be life-threatening, but today it is managed as a long-term condition. In a large French study of 383 patients followed for an average of about 5.5 years, between 6% and 13% died during follow-up, depending on their antibody type, and deaths became less common in people diagnosed after 1996.

The biggest threat to life is heart involvement. Older age at diagnosis also raises the risk. Relapses are common, so long-term follow-up matters.

Advertisement

What is Churg-Strauss syndrome?

Churg-Strauss syndrome is now called eosinophilic granulomatosis with polyangiitis (EGPA). It is a rare type of vasculitis (inflammation of small blood vessels) linked to asthma and a high level of eosinophils, a type of white blood cell.

  • Most people diagnosed have asthma, often starting or getting worse in adulthood, sometimes years before other symptoms.
  • The average age at diagnosis is around 40 to 50, though children and older adults can be affected.
  • Men and women are affected about equally.
  • In the US, it is estimated to affect roughly 3 to 31 people per million.

The condition often develops in three overlapping stages, though not everyone goes through all of them:

  1. Allergic stage: new or worsening asthma, nasal allergies, sinus infections and nasal polyps, often for years.
  2. Eosinophilic stage: eosinophils build up in tissues, causing coughing, wheezing, stomach pain or bleeding.
  3. Vasculitic stage: blood vessel inflammation reduces blood flow to organs, such as the nerves, skin, heart and kidneys.

What affects life expectancy?

Heart involvement

Inflammation of the heart muscle (cardiomyopathy) or the lining around the heart, abnormal heart rhythms, heart failure and heart attacks can occur. In the French study, about 16% of patients had cardiomyopathy, and it was one of the main factors linked to death. Heart disease is a major cause of death in untreated EGPA.

Kidneys, gut and nervous system

Kidney inflammation (glomerulonephritis) is uncommon but can be serious. Inflammation in the gut can cause pain and bleeding. Nerve damage is the most common feature, affecting about half of patients, and usually causes numbness, tingling, pain or weakness in the hands and feet. Strokes can also occur.

Antibody type (ANCA)

About 30-50% of people test positive for antibodies called ANCA. This group tends to have more kidney, nerve and sinus problems but less heart involvement. In the French study, deaths were less common in the ANCA-positive group (5.6%) than in the ANCA-negative group (12.5%).

Relapses

Relapses are common: in the French study, between about 1 in 4 and 1 in 3 patients had a vasculitis relapse. Regular follow-up helps doctors spot a flare early.

Long-term steroid use

Many people need low-dose steroids for years to control breathing symptoms. Newer treatments help reduce how much steroid is needed.

Advertisement

Treatment

There is no cure, but treatment can put the disease into remission.

  • Steroids (prednisone or methylprednisolone) are the first treatment, started at a high dose and then gradually tapered.
  • Severe disease is usually treated with steroids plus cyclophosphamide or rituximab.
  • Mepolizumab (Nucala) was the first drug approved by the FDA for EGPA. It blocks IL-5, a signal that drives eosinophils, and helps keep the disease in remission.
  • Benralizumab (Fasenra) gained FDA approval for adults with EGPA in 2024 and helps with remission and tapering steroids.
  • Other immune-suppressing medicines (DMARDs) may also be used to keep the disease in remission.

What causes it?

The exact cause is unknown. It is thought to involve a mix of genetic, immune and environmental factors. In the past, some cases were linked to starting certain asthma medicines. Experts now think these cases were more likely unmasked when steroid treatment for asthma was reduced, rather than caused by the new medicine. If you have asthma, don't stop or change any medicine without talking to your doctor.

When to get help

See a doctor if you have asthma or nasal allergies that suddenly get worse, a runny nose that won't go away (especially with facial pain), unusual rashes, digestive problems, or burning, numbness or tingling in your hands or feet.

Call 911 (UK: 999) or go to the ER for chest pain, severe shortness of breath, coughing up blood, vomiting blood or black stools, sudden weakness on one side, or confusion.

References

  1. Eosinophilic Granulomatosis with Polyangiitis. National Organization for Rare Disorders (NORD). Accessed 13 November 2026.
  2. EGPA (formerly Churg-Strauss syndrome) - Symptoms and causes. Mayo Clinic. Accessed 13 November 2026.
  3. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort (Arthritis Rheum, 2013). Arthritis & Rheumatism (PubMed). Accessed 13 November 2026.

Keep reading

Advertisement